Dyne Therapeutics Stock (NASDAQ: DYN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.398M |
Day Range | - - - |
52 Wk Range | 6.400 - 30.269 |
Market Cap | $2.042B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 11.52% |
Days to Cover | 5.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Fusion Pharmaceuticals (NASDAQ:FUSN), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by Oppenheimer on Tuesday, March 26, 2024. The analyst firm set a price target for 47.00 expecting DYN to rise to within 12 months (a possible 98.35% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $23.695 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.